Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma
Saved in:
| Main Authors: | Yong Pan, Yiru Zhang, Daiwen Mao, Zhou Fang, Yingqiu Ma, Danwen Jin, Shibo Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2024-11-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.4c08010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
by: Xuan-Yu Gu, et al.
Published: (2025-03-01) -
Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma
by: Zhen Wang, et al.
Published: (2025-07-01) -
and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01) -
Integrated multi-omics analysis identifies TPX2 as a potential prognostic and immunological biomarker in hepatocellular carcinoma
by: Hui Peng, et al.
Published: (2025-09-01) -
A mitochondrial-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma
by: Hongli Shu, et al.
Published: (2025-07-01)